Vaccines for the management of dermatophyte and superficial yeast infections

Phospholipid molecular species distributions of Candida isolates from the UK and Iran

AIMS

Some species of Candida have been shown to differ with respect to their polar lipid fingerprints when analysed by fast atom bombardment mass spectrometry (FABMS). The aims of this study were to contribute to the existing body of information by (i) examining representatives of species not previously examined and (ii) seeking strains differences associated with country of origin (UK or Iran).

METHODS AND RESULTS

FABMS analysis was performed on extracted lipids of 22 strains representing eight species of Candida. The most abundant anion (19 isolates) in spectra was with mass to charge (m/z) 281, corresponding to C18:1 carboxylate. The major phospholipid analogue anions were m/z 515 and 501 (13 strains). These anions were putatively identified as the phosphatidyl molecular species PA(23 : 2) and PA(22 : 2) respectively. Data for strain pairs were compared using the Pearson's coefficient of linear correlation. The values generated were used to cluster strains by nearest-neighbour linkage, using both carboxylate and phospholipid analogue anion data. Isolates of C. parapsilosis were clearly distinct from other isolates. Iranian isolates tended to cluster together when phospholipid anion data were used. However, if carboxylate anion data were used, four Iranian isolates of C. albicans were tightly clustered with three UK isolates, of which two were C. albicans and one was C. dubliniensis.

CONCLUSION

It is concluded that both lower, and higher, mass peaks in FABMS spectra can be of potential value in comparing Candida isolates from different countries and from different species.

SIGNIFICANCE AND IMPACT OF THE STUDY

When polar lipids of different Candida species are compared, it is important to bear in mind that geographical differences affect results as has been observed with bacteria in similar studies.

Terbinafine hydrochloride treatment of Microsporum canis experimentally-induced ringworm in cats

Cats represent the most important source of Microsporum canis infection to people. Terbinafine hydrochloride is commonly used in the treatment of microsporosis. Its fungicidal action permits short period of treatment. It was our objective to evaluate the effectiveness of this drug in treatment of microsporosis in cats. We treated nine experimentally M. canis infected cats with terbinafine at a dose of 10-20mg/kg SID (low-dose group, LDG), nine cats with 30-40mg/kg SID (high-dose group, HDG), and nine cats were left untreated (control group, CG). The drug's levels in cats' plasma and hair were measured by a reversed-phase high performance liquid chromatographic method (RP-HPLC) and the cats' cure was followed by Wood's lamp illumination, microscopic exam and fungal culture. We showed no difference between the clinical course in CG and LDG, but HDG were significantly differentiated from both other groups. Terbinafine levels in plasma at 120 days of treatment were not statistically different among LDG (4.13 microg/l) and HDG (5.48 microg/l), but levels in hair of LDG (1.24 microg/l) and HDG (3.62 microg/l) were significantly different. Terbinafine can be used for the treatment of microsporosis in cats in the dose of 30-40mg/kg SID.

Investigations of a killed dermatophyte cell-wall vaccine against infection with Microsporum canis in cats

A laboratory-prepared killed Microsporum canis cell-wall vaccine was evaluated under conditions simulating an accidental infection of a cattery, by inoculating eight- to nine-week-old cats with the vaccine or with a placebo control. The vaccinated cats developed high titres of anti-dermatophyte IgG as measured by an ELISA, and a small cell-mediated response against M canis as measured by a lymphocyte blastogenesis assay, using a whole fungus extract. After being inoculated the cats were challenged by the introduction of an infected cat into the same room. All the vaccinated and control cats became culture-positive for M canis within four weeks of the introduction of the infected cat. Four of the six control cats and all the vaccinated cats developed lesions consistent with dermatophytosis within 16 weeks after exposure to the infected cat.

Cutaneous defenses against dermatophytes and yeasts

Predispositions to the superficial mycoses include warmth and moisture, natural or iatrogenic immunosuppression, and perhaps some degree of inherited susceptibility. Some of these infections elicit a greater inflammatory response than others, and the noninflammatory ones are generally more chronic. The immune system is involved in the defense against these infections, and cell-mediated immunity appears to be particularly important. The mechanisms involved in generating immunologic reactions in the skin are complex, with epidermal Langerhans cells, other dendritic cells, lymphocytes, microvascular endothelial cells, and the keratinocytes themselves all participating in one way or another. A variety of defects in the immunologic response to the superficial mycoses have been described. In some cases the defect may be preexistent, whereas in others the infection itself may interfere with protective cell-mediated immune responses against the organisms. A number of different mechanisms may underlie these immunologic defects and lead to the development of chronic superficial fungal infection in individual patients. Although the immunologic defects appear to be involved in the chronicity of certain types of cutaneous fungal infections, treatment of these defects remains experimental at the present time.

Immunogenicity in calves of a crude ribosomal fraction of Trichophyton verrucosum: a field trial

This paper describes a field trial involving 13 calves raised on a farm known to be endemic for Trichophyton verrucosum infection. Seven calves were immunized by subcutaneous inoculations with a crude ribosomal fraction (CRF) of T. verrucosum suspended in aluminium hydroxide as adjuvant. Six animals were sham-immunized with buffer suspended in the adjuvant and served as controls. Two injections were given: one at the age of 2 weeks and a second 2 weeks later. CRF was prepared from T. verrucosum cultures grown in a vitamin-enriched liquid medium. The fungal mat was disrupted mechanically and CRF was separated from the cell-free extract by differential ultracentrifugation. The CRF was characterized biochemically (RNA and protein content) and physically (electron microscopy). The protection induced by vaccination was assessed through a clinical follow-up of the animals to determine the presence and duration of dermatophyte infection following their exposure to a T. verrucosum-contaminated environment. Vaccination with the CRF resulted in a statistically significant decrease in the period during which clinical signs of dermatophytosis were observed (from a mean of 9.5 weeks to 3.7 weeks). To assess the humoral response, serum samples were taken before each vaccination and 2 weeks after the second inoculation. For the cell-mediated immune (CMI) response assessment, whole-blood samples were taken 2 weeks after the second vaccination. The presence of anti-T. verrucosum antibodies in the sera was determined by ELISA and the CMI response was assessed in vitro by the lymphocyte stimulation test.(ABSTRACT TRUNCATED AT 250 WORDS)